Spis treści:
4. PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
| Raport bieżący nr | 2 | / | 2021 | |||||||||
| Data sporządzenia: | 2021-01-06 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| The Update on Commercial Rollout of CompuFlo® Epidural System | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company”, “the Issuer”) today today provided the update on commercial rollout of CompuFlo® Epidural System. The Board of Directors of the Issuer is pleased to report that the Company is gaining traction with its CompuFlo® Epidural System. Specifically, the Company announced it has begun selling CompuFlo® disposables to the University of Texas Medical Branch at Galveston (UTMB), an institution of the University of Texas System and agency of the State of Texas. The Board of Directors of the Issuer anticipates adding additional hospitals during the first quarter of 2021 and remains steadfast in its goal of establishing the CompuFlo® Epidural System as the new standard of care in epidural anesthesia. Given the strong cash position at the end of the third quarter of its parent, The Board of Directors of the Issuer believes that the Company is well funded to support its sales and marketing activities around the CompuFlo® Epidural System and have no plans to raise capital for the foreseeable future. |
||||||||||||
| MESSAGE (ENGLISH VERSION) | |||
INFORMACJE O PODMIOCIE >>>
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2021-01-06 | Joseph D'Agostino | Joseph D'Agostino | Chief Financial Officer | ||
Źródło:Komunikaty spółek (ESPI)
